CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-19 | Kulkarni Samarth Chief Executive Officer | Sale | −47,837 | $49.78 | $2.4M | 311,899 |
| 2026-10-14 | George Simeon Director | Sale 10b5-1 | −14,514 | $49.63 | $720K | 15,486 |
| 2026-10-14 | KASINGER JAMES R. General Counsel and Secretary | Sale | −1,040 | $49.26 | $51K | 95,857 |
| 2026-10-14 | Kulkarni Samarth Chief Executive Officer | Sale | −4,098 | $49.26 | $202K | 259,736 |
| 2026-10-06 | KASINGER JAMES R. General Counsel and Secretary | Sale 10b5-1 | −1,990 | $60.04 | $119K | 94,784 |
| 2026-09-22 | KASINGER JAMES R. General Counsel and Secretary | Sale 10b5-1 | −10,400 | $60.24 | $626K | 94,784 |
| 2026-09-17 | Behbahani Ali Director | Sale | −13,679 | $57.09 | $781K | 16,637 |
| 2026-05-29 | Patel Naimish Chief Medical Officer | Sale | −3,786 | $55.62 | $211K | 19,357 |
| 2026-03-23 | KASINGER JAMES R. General Counsel and Secretary | Sale | −3,182 | $46.78 | $149K | 94,308 |
| 2026-03-23 | Kulkarni Samarth Chief Executive Officer | Sale | −10,020 | $46.78 | $469K | 255,501 |
| 2026-03-23 | Prasad Raju Chief Financial Officer | Sale | −3,708 | $46.78 | $173K | 15,565 |
| 2026-03-16 | Patel Naimish Chief Medical Officer | Sale | −3,150 | $48.26 | $152K | 13,143 |
| 2026-03-16 | Prasad Raju Chief Financial Officer | Sale | −5,848 | $48.26 | $282K | 17,794 |
| 2026-03-16 | Prasad Raju Chief Financial Officer | Sale | −4,021 | $48.26 | $194K | 13,773 |
| 2026-03-16 | KASINGER JAMES R. General Counsel and Secretary | Sale | −3,450 | $48.26 | $166K | 91,240 |
| 2026-03-16 | Kulkarni Samarth Chief Executive Officer | Sale | −10,349 | $48.26 | $499K | 245,834 |
| 2026-03-11 | KASINGER JAMES R. General Counsel and Secretary | Sale | −2,800 | $52.80 | $148K | 87,815 |
| 2026-03-11 | Kulkarni Samarth Chief Executive Officer | Sale | −9,798 | $52.80 | $517K | 235,558 |
| 2026-02-19 | Kulkarni Samarth Chief Executive Officer | Sale | −6,967 | $52.58 | $366K | 226,106 |
| 2026-02-19 | KASINGER JAMES R. General Counsel and Secretary | Sale | −2,112 | $52.58 | $111K | 85,115 |
Page 1 of 16 · 309 trades